You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

progressive hairy cell leukemia, initial treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Patients

Not yet recruiting
  • Hairy Cell Leukemia
    • (no location specified)
    May 5, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +71 more
    • Chicago, Illinois
    • +5 more
    Oct 8, 2021

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

    Active, not recruiting
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox-tdfk
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

      Completed
      Has Results
      • Adult Grade III Lymphomatoid Granulomatosis
      • +88 more
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Apr 14, 2021

      Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

      Recruiting
      • Hairy Cell Leukemia
      • Low dose vemurafenib plus rituximab
      • La Jolla, California
        Scripps MD Anderson Cancer Center
      May 19, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

      Terminated
      Has Results
      • Adult Grade III Lymphomatoid Granulomatosis
      • +116 more
      • brentuximab vedotin
      • +2 more
      • Chicago, Illinois
      • +2 more
      Aug 30, 2021

      Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)

      Active, not recruiting
      Has Results
      • Hairy Cell Leukemia
      • Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 13, 2022

      Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

      Not yet recruiting
      • Relapsed/Refractory Waldenstrom Macroglobulinemia
      • +3 more
      • Brexucabtagene Autoleucel
      • +2 more
      • (no location specified)
      Sep 8, 2022

      Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

      Active, not recruiting
      • Hairy Cell Leukemia
      • +2 more
      • New Haven, Connecticut
      • +8 more
      Feb 7, 2022

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Zanubrutinib Pill
      • +2 more
      • New York, New York
        Weill Cornell Medicine/NewYork-Presberteryian Hospital
      Dec 6, 2022

      Patients Previously Treated WithMustang Bio CAR-T Cell

      Enrolling by invitation
      • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
      • +10 more
      • Prior MB-102 CAR-T cell investigational product.
      • Prior MB-106 CAR-T cell investigational product.
      • Duarte, California
      • +4 more
      Dec 8, 2022

      Moxetumomab Pasudotox-tdfk (LUMOXITI)

      Recruiting
      • Hairy Cell Leukemia
        • Pueblo, Colorado
        • +1 more
        Aug 17, 2022

        Hairy Cell Leukemia Patient Data Registry

        Recruiting
        • Leukemia, Other
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Apr 1, 2021

          Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

          Active, not recruiting
          • Chronic Lymphocytic Leukemia (CLL)
          • Stamford, Connecticut
          • +4 more
          Dec 2, 2022

          Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

          Recruiting
          • Recurrent Acute Leukemia
          • +16 more
          • Duarte, California
            City of Hope Medical Center
          Nov 22, 2022

          Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

          Recruiting
          • Leukemia, Acute Myeloid
          • +7 more
          • Denver, Colorado
          • +4 more
          Aug 29, 2022

          CLL/SLL, Waldenstrom Macroglobulinemia, Follicular Lymphoma Trial in Cincinnati, Columbus, Salt Lake City (LP-168)

          Recruiting
          • CLL/SLL
          • +6 more
          • Cincinnati, Ohio
          • +2 more
          May 7, 2022

          Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

          Active, not recruiting
          • Adult Grade III Lymphomatoid Granulomatosis
          • +23 more
          • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
          • +2 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023

          Leukemia, Myeloid, Acute Trial (Cytarabine, Venetoclax, CPX-351)

          Not yet recruiting
          • Leukemia, Myeloid, Acute
          • (no location specified)
          Nov 25, 2022

          Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

          Active, not recruiting
          • Leukemia
          • Lymphoma
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Oct 11, 2022

          Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • +2 more
          • New York, New York
            Weill Cornell Medicine
          Mar 29, 2022

          B-cell Chronic Lymphoid Malignancies Markers

          Recruiting
          • Chronic Lymphocytic Leukemia
          • +5 more
            • Strasbourg, France
              Hematology Laboratory - Strasbourg University Hospitals
            Jul 2, 2021